Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 82 clinical trials
Balloon vs. Self Expanding Transcatheter Valve for Degenerated Bioprosthesis (BASELINE)

Transcatheter aortic valve implantation (TAVI) serves a growing spectrum of patients with symptomatic severe aortic stenosis (AS). Approximately 80% of surgical aortic valve replacements is

transcatheter aortic valve implantation
tavi
regurgitation
aortic valve replacement
stenosis
  • 1 views
  • 04 Oct, 2022
  • 4 locations
Microvascular Function in Patients Undergoing Transcatheter Aortic Valve Implant (TAVI) for Severe Symptomatic Aortic Stenosis: Association With Myocardial Fibrosis

Microvascular function in patients undergoing Transcatheter Aortic Valve Implant (TAVI) for severe symptomatic aortic stenosis: association with myocardial fibrosis

  • 0 views
  • 04 Oct, 2022
  • 1 location
Effect of Antifibrotic Therapy on Regression of Myocardial Fibrosis After Transcatheter Aortic Valve Implantation (TAVI) in Aortic Stenosis Patients With High Fibrotic Burden (Reduce-MFA)

The aim of the study is to evaluate the effect of antifibrotic therapy on regression of myocardial fibrosis after TAVI in patients with baseline high fibrotic burden. Therefore, patients will be

  • 0 views
  • 12 Jul, 2022
  • 1 location
The CASPER Registry

bicuspid aortic stenosis type I treated by TAVI with Evolut® Pro prostheses (23 -26-29) and Evolut® R 34.

  • 0 views
  • 09 Jun, 2022
  • 1 location
Sedation or General Anesthesia During TAVR (ANESTAVI)

Transcatheter aortic valve replacement TAVR is become the reference method for patients with severe aortic stenosis who are contraindicated or at risk for surgical aortic replacement. Initially performed under general anesthesia (GA), recent developpement of minimalist approach of TAVR include the use of local anesthesia (LA) with or without conscious …

  • 0 views
  • 23 Mar, 2022
  • 2 locations
Comparison of Eligible TAVI-valves - Cohort B (Compare-TAVI)

The study performs head-to-head comparison of two TAVI-valves: Sapien and Myval.

  • 0 views
  • 04 Oct, 2022
  • 1 location
Von Willebrand Factor Point-of-care Testing to Improve Minimally Invasive TAVI Outcomes (WITAVI-REAL)

Paravalvular regurgitation (PVR) is an important complication of Transcatheter Aortic Valve Implantation (TAVI) that is associated with a 2.5-fold increase risk of mortality. Transesophageal

transcatheter aortic valve implantation
symptomatic aortic stenosis
tavi
regurgitation
stenosis
  • 10 views
  • 27 May, 2022
  • 1 location
Optimal Timing of Transcatheter Aortic Valve Implantation and Percutaneous Coronary Intervention - The TAVI PCI Trial

The primary objective of this study is to compare, in patients with severe aortic stenosis and concomitant coronary artery disease accepted for transcatheter aortic valve implantation (TAVI) and

arterial disease
coronary artery disease
syncope
ejection fraction
exercise stress test
  • 0 views
  • 15 Oct, 2021
  • 1 location
Periprocedural Continuation Versus Interruption of Oral Anticoagulant Drugs During Transcatheter Aortic Valve Implantation (POPular PAUSE TAVI)

Transcatheter aortic valve implantation (TAVI) is a rapidly growing treatment option for patients with aortic valve stenosis. Stroke is a feared complication of TAVI, with an incidence of around

vitamin k
myocardial infarction
anticoagulation therapy
infarct
aortic valve stenosis
  • 8 views
  • 24 Mar, 2022
  • 1 location
Randomized Trial of TAVI vs. SAVR in Patients With Severe Aortic Valve Stenosis at Intermediate Risk of Mortality (DEDICATE)

valve implantation (TAVI) or surgical aortic valve replacement (SAVR) to test, whether TAVI is non-inferior to SAVR, as measured by all-cause mortality or stroke after 1 and 5 years.

syncope
angina pectoris
heart disease
valvular disease
aortic valve replacement
  • 43 views
  • 25 Feb, 2022
  • 37 locations